English
Earnings 2026
UnitedHealth earnings preview: $408 marks key resistance
UnitedHealth reports quarterly earnings on 13 October as its shares approach a key technical decision point. The downtrend from July remains intact, although buyers have recently defended the lower Keltner band. A break below $356 would bring April’s unfilled gap into focus, while a sustained move above $408 would materially improve the chart outlook.
At a glance
UnitedHealth shares have fallen approximately 18% from their July high. The earnings report could determine whether the recent stabilisation holds. A sustained breakout above $408 would provide an important recovery signal. Below $356, the risk would shift towards a retreat into April’s unfilled price gap.
UnitedHealth Q3 earnings: date and expectations
UnitedHealth will release its third-quarter 2026 results on Tuesday, 13 October, before the US market opens. The earnings call begins at 14:00 Central European Summer Time (CEST).
| Metric | Timing or expectation |
|---|---|
| Results release | 13 October 2026, before the US market opens |
| Earnings-calendar time | Approximately 11:55 CEST; exact release time not officially confirmed |
| Expected revenue | $111.38 billion |
| Expected earnings per share | $4.12 |
Consensus figures reflect the calendar snapshot used for this analysis. Estimates can vary between providers and collection times.
Medical costs at UnitedHealthcare and earnings performance at Optum remain the main fundamental considerations. In Q2, the medical care ratio declined to 86.7%, from 89.4% a year earlier. UnitedHealth also raised its full-year adjusted earnings guidance to $19.50–$20.00 per share. The next report will test whether that improvement is continuing.
Seasonality: a historically favourable year-end window
The 25-year Seasonax study shows an average gain of 8.81% between 9 October and 29 December. Returns were positive in 20 of 25 years, a historical frequency of 80%, with a median gain of 6.55%.
However, both 2024 and 2025 were negative. The pattern therefore offers favourable historical context rather than a reliable forecast of the immediate earnings reaction.
UnitedHealth: 25-Year Seasonal Pattern
Options imply an earnings move of approximately ±8.18%
The options snapshot indicates an expected earnings move of ±8.18%, equivalent to approximately ±$30.98. This highlights the potential for a substantial reaction around the release. It neither predicts the direction nor places a limit on the eventual share-price move.
Analyst consensus: an average target of $487.22
The TipRanks snapshot shows a “Strong Buy” consensus, comprising 17 Buy and four Hold ratings, with no Sell ratings.
The average 12-month target is $487.22, with individual forecasts ranging from $430 to $529. Relative to the snapshot’s $378.57 reference price, this represents indicated upside of 28.70%. These longer-term targets should be distinguished from the short-term earnings reaction.
UnitedHealth: Analyst Ratings and 12-Month Price Targets
Technical analysis: the downtrend from July remains intact
Since reaching approximately $461 in July, UnitedHealth has formed a sequence of lower highs and lower lows. The daily chart shows a latest closing price of $378.58, approximately 18% below that peak.
Buyers have recently defended the lower Keltner band, with the subsequent rebound taking the shares back towards the channel’s midpoint. This recovery has yet to establish a sustained trend reversal.
On the downside, the recent support area around $360–$365 is the first reference point. Below it lies the marked April support level near $356. A break beneath this level would bring the unfilled April gap, approximately $327–$346, into focus.
A move to $340 would represent a partial gap fill. The gap would only be fully closed at its lower boundary near $327.
The RSI is also testing a decision point: 48.5, the threshold marked for this analysis. A sustained recovery above it would support the rebound. Failure to clear it, alongside a breakdown in price support, would strengthen the case for the downtrend to continue.
On the upside, a sustained breakout above $408 would be the key signal. It would interrupt the sequence of lower highs and open the possibility of resuming the preceding upward move. The next reference levels would be $420 and $440, followed potentially by the July high near $461.
UnitedHealth Daily Chart: Key Resistance at $408
UnitedHealth: potential long and short setups
| Scenario | Trigger and potential entry | Potential targets | Protection and invalidation |
|---|---|---|---|
| Long: confirmed breakout | Daily close above $408, followed by a successful retest of the breakout area. RSI above 48.5 provides additional confirmation. | $420, followed by $440 and potentially $461 | Protection below the retest low. A sustained move back below $408 would challenge the breakout. |
| Short: downtrend continuation | Daily close below $356, followed by a failed retest of that level from underneath. | $346, followed by $340; full gap fill near $327 | Protection above the retest high. A sustained recovery above $356 would weaken the setup. |
UNH: Five-Year Share Price Performance
Ready to start your trading journey?
Open an IG account now
Follow us online:
